Pfizer boosts 2022 COVID vaccine forecast, looks to pivot with deals, new drugs
Pfizer Inc. on Tuesday raised its forecast for 2022 sales of its coronavirus disease 2019 (COVID-19) vaccine by $2 billion to $34
Pfizer Inc. on Tuesday raised its forecast for 2022 sales of its coronavirus disease 2019 (COVID-19) vaccine by $2 billion to $34
BRUSSELS — Channeling climate compensation payments through existing funds will not work for vulnerable communities, a team of international researchers said on
WASHINGTON — As Earth’s largest animals, blue whales are mighty big eaters, gulping tons of food each day. They also now are
WASHINGTON — US President Joseph R. Biden on Monday called on oil and gas companies to use their record profits to lower
TOKYO — Chinese fashion retailer Shein said on Tuesday it would open its first bricks-and-mortar store in Japan this month, in a
TOKYO — Asia’s factory output weakened in October as global recession fears and China’s zero-COVID policy hurt demand, business surveys showed on
SEOUL — South Korea moved to calm public outrage on Tuesday over a Halloween party crush that killed more than 150 people,
NEW DELHI — India will use next week’s U.N. climate conference to urge rich countries to keep their promise to give $100
HONG KONG – Macau carried out mass testing of its 700,000 residents on Tuesday after the emergence of COVID–19 cases in the past week, including at a major casino that prompted authorities to
JAKARTA – Indonesia‘s food and drug agency said on Monday it had revoked licenses for syrup-type drug production by two local firms for violating manufacturing rules, as it investigates the deaths of